Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/08/2014EP2785716A1 Novel crystalline form of ticagrelor and process for the preparation thereof
10/08/2014EP2785715A1 Substituted pyridine derivatives as fabi inhibitors
10/08/2014EP2785714A1 Improved modulators of hec1 activity and methods therefor
10/08/2014EP2785713A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
10/08/2014EP2785712A1 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof
10/08/2014EP2785711A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785710A1 Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
10/08/2014EP2785709A1 Aminopyrimidine derivatives as lrrk2 modulators
10/08/2014EP2785707A1 Novel 2h-indazoles as ep2 receptor antagonists
10/08/2014EP2785706A1 Substituted 4 - phenyl - pyridines for the treatment of nk-1 receptor related diseases
10/08/2014EP2785705A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
10/08/2014EP2785704A1 Novel combination of n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide and folfox
10/08/2014EP2785702A1 Crystalline dapagliflozin hydrate
10/08/2014EP2785701A2 Crystalline forms of carbazitaxel and process for preparation thereof
10/08/2014EP2785700A1 Anticoagulant reversal agents
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785696A1 Novel compounds
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785694A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/08/2014EP2785693A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/08/2014EP2785691A1 Donepezil pamoate, preparation method and its use
10/08/2014EP2785690A1 Piperidine derivatives, pharmaceutical compositions and uses thereof
10/08/2014EP2785689A1 Amorphous ezatiostat ansolvate
10/08/2014EP2785683A1 Inkt cell modulators and methods of using the same
10/08/2014EP2785379A1 Peptide-mediated delivery of active agents across the blood-brain barrier
10/08/2014EP2785356A1 Use of pullulan for alleviating the appearance of scars or scar tissue
10/08/2014EP2785355A1 Targeting micrornas mir-409-5p, mir-379 and mir-154* to treat prostate cancer bone metastasis and drug resistant lung cancer
10/08/2014EP2785354A1 Composition comprising vicenin-2 having a beneficial effect on neurological and/or cognitive function
10/08/2014EP2785353A1 Prophylactic compositions for management of microbial infections in patients with brain injury
10/08/2014EP2785352A1 Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
10/08/2014EP2785349A1 Combination treatment of cancer
10/08/2014EP2785348A1 Peptide deformylase inhibitors
10/08/2014EP2785347A1 Lurasidone novel dosage regimens and use thereof for the treatment, prevention, and/or management of at least one cns disorder
10/08/2014EP2785346A1 Opsin-binding ligands, compositions and methods of use
10/08/2014EP2785345A1 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for retinal neuroprotection
10/08/2014EP2785344A1 Phacetoperane for the treatment of attention-deficit hyperactivity disorder
10/08/2014EP2785343A1 Pharmaceutical composition for preventing or treating hyperlipidemia
10/08/2014EP2785342A1 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
10/08/2014EP2785341A1 Aryl derivatives for controlling ectoparasites
10/08/2014EP2785340A1 Compositions and methods for treating hepatitis c virus
10/08/2014EP2785339A2 Metalloporphyrin neurological treatments
10/08/2014EP2785338A1 Methods of treatment and prevention of eye diseases
10/08/2014EP2785337A1 Acamprosate formulations, methods of using the same, and combinations comprising the same
10/08/2014EP2785336A1 Use of pegylated alcohols for the treatment of actinic keratosis
10/08/2014EP2785335A1 Methods and pharmaceutical compositions for the treatment of darier disease
10/08/2014EP2785334A1 Transdermal therapeutic system for administering fentanyl or an analogue thereof
10/08/2014EP2785332A1 A process for the preparation of solid dispersion of lopinavir and ritonavir
10/08/2014EP2785331A1 Dry coated tablet
10/08/2014EP2785328A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine
10/08/2014EP2785327A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
10/08/2014EP2785325A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
10/08/2014EP2785314A1 Topical composition containing a combination of at least one blue algae extract with at least one alpha hydroxy acid or one of the salts thereof
10/08/2014EP2785204A1 Zero calorie polyphenol aqueous dispersions
10/08/2014EP2785203A1 Increasing the bioavailability of hydroxycinnamic acids
10/08/2014EP2785177A1 Antimicrobial animal product
10/07/2014USRE45183 Heteroaryl-ureas and their use as glucokinase activators
10/07/2014US8854138 Buffer amplifier
10/07/2014US8853452 Compounds, their syntheses, compositions, and methods to treat cancer
10/07/2014US8853437 Anti-inflammatory compounds
10/07/2014US8853430 Crystalline hydrochloride salt of darunavir
10/07/2014US8853424 Protein cross-linking inhibitor
10/07/2014US8853419 Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
10/07/2014US8853418 Cyclopentylpyrazoles as N-type calcium channel blockers
10/07/2014US8853416 Chemical compounds
10/07/2014US8853415 Modulators of ATP-binding cassette transporters
10/07/2014US8853412 Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
10/07/2014US8853409 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/07/2014US8853408 Cyclopropylamines as LSD1 inhibitors
10/07/2014US8853406 Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53
10/07/2014US8853405 Crystalline forms of pitavastatin calcium
10/07/2014US8853404 Muscarinic acetylcholine receptor antagonists
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853394 Pharmacokinetically improved compounds
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853372 Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
10/07/2014US8853361 Preparation, for use, in particular, for tissue augmentation and healing
10/07/2014US8853282 Topical liquid insecticide compositions
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853280 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
10/07/2014US8853279 Method for determining sensitivity or resistance to compounds that activate the brain serotonin system
10/07/2014US8853278 Compositions comprising a biocidal polyamine
10/07/2014US8853277 Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
10/07/2014US8853276 Guanidine derivatives in cinnamic series
10/07/2014US8853275 Concurrent therapy regime/regimen for the treatment of acne related diseases
10/07/2014US8853274 Compositions and methods for targeting glioblastomas cells
10/07/2014US8853273 Medicinal agent for prevention and/or treatment of hepatocellular carcinoma
10/07/2014US8853272 Method for treating an inflammation or lesion caused by a virus
10/07/2014US8853271 Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid
10/07/2014US8853270 Substituted stilbenes and their reactions
10/07/2014US8853269 Composition and method for treating infections and promoting intestinal health
10/07/2014US8853268 Ophthalmic solution
10/07/2014US8853267 N-alkylcarbonyl-amino acid ester compounds and their use for skin irritation, itch, and pain
10/07/2014US8853266 Selective androgen receptor modulators for treating diabetes
10/07/2014US8853265 Oral composition to reduce cold symptoms and duration of same
10/07/2014US8853264 Use of lignan compounds for treating or preventing inflammatory disease
10/07/2014US8853263 Co-therapy for the treatment of epilepsy and related disorders
10/07/2014US8853262 pKa buffered vitamin C composition and method
10/07/2014US8853261 Nutraceutical composition from Garcinia mangostana
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 7860